Product

Azvudine

Aliases

FNC

7 clinical trials

2 indications

Indication

Indication

Clinical trial

A Non-interventional Real-world Study Evaluating the Efficacy and Safety of Azvudine in Nursing Home Patients With Mild/Normal COVID-19

Status: Not yet recruiting, Estimated PCD: 2023-03-15

Clinical trial

A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected With SARS-CoV-2 in China

Status: Recruiting, Estimated PCD: 2023-04-15

Clinical trial

A Phase II/III Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Azvudine in Preventing SARS-Cov-2 Infection in Household Contacts of Individuals Infected With SARS-CoV-2

Status: Recruiting, Estimated PCD: 2024-06-15

Clinical trial

Real-World Effectiveness and Safety of Oral Azvudine in Hospitalized Patients With COVID-19: A Multicenter, Retrospective, Cohort Study

Status: Completed, Estimated PCD: 2024-01-15

Clinical trial

Efficacy and Safety of Azvudine in the Treatment of Patients With Corona Virus Disease (COVID-19) Pneumonia in China: an Multi-center Observational, Ambispective Cohort, Real-world Study

Status: Recruiting, Estimated PCD: 2023-11-16

Clinical trial

Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect

Status: Active (not recruiting), Estimated PCD: 2023-10-25

Clinical trial

A Prospective Multicenter, Randomized, Controlled Clinical Trial of the Safety and Efficacy of Azvudine vs. Nirmatrelvir-Ritonavir in Hospitalized Patients With Moderate to Severe COVID-19 Infection

Status: Recruiting, Estimated PCD: 2023-05-21